Abstract: A tape includes, in a cross-sectional shape: a first and a second portion which are configured to be at least partially in opposition. The first portion includes: thick portions provided in corresponding one of a first and a third region, out of the first, a second, and the third region in a width direction of the tape; a first and a second thin portion provided at respective both end portions, in the width direction, of the second region positioned between the first and the third region; and at least one intermediate portion provided between the first and the second thin portion. The second portion includes: thick portions provided in corresponding one of the first and the third region and extending beyond end portions, in the width direction, of the second region; and at least one third thin portion provided in the second region and opposed to the intermediate portion.

Abstract: In the method of manufacturing an image display apparatus according to the present invention, a liquid photocurable resin composition that does not contain a thermal polymerization initiator is coated on the surface of a light-transmissive cover member including a light shielding layer or the surface of an image display member in a thickness thicker than that of the light shielding layer, and thereafter UV rays are irradiated in that state for curing to form a light-transmissive cured resin layer. Then, the image display member and the light-transmissive cover member are laminated to each other via the light-transmissive cured resin layer to obtain an image display apparatus.

Abstract: To make validity of a prediction model created by machine learning be able to be verified with appropriate accuracy and efficiency. A software test apparatus includes a storage device configured to store a prediction model, and an arithmetic device. The arithmetic device is configured to accept inputs of a precondition, a constraint condition, and an approximation threshold value, convert the prediction model into a logical expression, analyze an approximation range based on the approximation threshold value with respect to the logical expression to simplify the logical expression, generate an inspection expression by combining the simplified logical expression with the precondition and negation of the constraint condition, search for, as a counterexample, a value satisfying the inspection expression, input the value to the prediction model to evaluate inspection accuracy when the counterexample exists, and output a result of the evaluation.

Abstract: Provided are a novel compound having an antagonistic activity for the P2X7 receptor, and a pharmaceutical composition having an antagonistic activity for the P2X7 receptor.

Abstract: To provide a blood flow sensor in which a fluctuation of measurement results is suppressed during measurement of the blood flow volume. A probe portion is provided with a sensor portion which has a laser diode generating laser light, a photodiode receiving light, and a sensor housing having a contact surface contacting a subject and which irradiates a subject with the laser light generated by the laser diode through the contact surface, receives reflected light from the subject in the photodiode, and outputs a signal relating to the received light amount, a holding portion holding the sensor housing so as to be movable in an up-and-down direction crossing the contact surface, and a coil spring absorbing and transmitting external force applied to the holding portion to the sensor portion.

Abstract: Provided are a novel compound having an antagonistic activity for the P2X7 receptor, and a pharmaceutical composition having an antagonistic activity for the P2X7 receptor.

Abstract: A compound represented by Formula (I): wherein or the like Y1 is O or the like; Z1 is C(R4) or N; Z2a is C(R5a) or the like; Z3a is C(R6) or the like; R4, R5a and R6 are each independently a hydrogen atom or the like; R1 is substituted or unsubstituted aromatic carbocyclyl or the like; R2a, R2b, R2c and R2d are each independently a hydrogen atom or the like; X is N(R7a) or the like; R7a is a hydrogen atom or the like; R3 is or the like Ring B is a 6-membered aromatic carbocycle or the like; R9a and R10a are each independently halogen or the like; n is an integer from 1 to 5; m is an integer from 0 to 4; and p 1 is an integer from 0 to 3, or a pharmaceutically acceptable salt thereof.

Abstract: A compound represented by Formula (I): wherein or the like, Y1 is O or the like; Z1 is C(R4) or N; Z2a is C(R5a) or the like; Z3a is C(R6) or the like; R4, R5a and R6 are each independently a hydrogen atom or the like; R1 is substituted or unsubstituted aromatic carbocyclyl or the like; R2a, R2b, R2c and R2d are each independently a hydrogen atom or the like; X is N(R7a) or the like; R7a is a hydrogen atom or the like; R3 is or the like, Ring B is a 6-membered aromatic carbocycle or the like; R9a and R10a are each independently halogen or the like; n is an integer from 1 to 5; m is an integer from 0 to 4; and p1 is an integer from 0 to 3, or a pharmaceutically acceptable salt thereof.

Abstract: Provided are a novel compound having an antagonistic activity for the P2X7 receptor, and a pharmaceutical composition having an antagonistic activity for the P2X7 receptor. The compound represented by Formula (I): wherein the symbols are defined in the specification, or a pharmaceutically acceptable salt thereof.

Abstract: A compound represented by Formula (I): wherein or the like Y1 is O or the like; Z1 is C(R4) or N; Z2a is C(R5a) or the like; Z3a is C(R6) or the like; R4, R5a and R6 are each independently a hydrogen atom or the like; R1 is substituted or unsubstituted aromatic carbocyclyl or the like; R2a, R2b, R2c and R2d are each independently a hydrogen atom or the like; X is N(R7a) or the like; R7a is a hydrogen atom or the like; R3 is or the like Ring B is a 6-membered aromatic carbocycle or the like; R9a and R10a are each independently halogen or the like; n is an integer from 1 to 5; m is an integer from 0 to 4; and p1 is an integer from 0 to 3, or a pharmaceutically acceptable salt thereof.

Abstract: A compound represented by Formula (I): Chemical Formula 1 wherein Chemical Formula 2 or the like Y1 is O or the like; Z1 is C(R4) or N; Z2a is C(R5a) or the like; Z3a is C(R6) or the like; R4, R5a and R6 are each independently a hydrogen atom or the like; R1 is substituted or unsubstituted aromatic carbocyclyl or the like; R2a, R2b, R2c and R2d are each independently a hydrogen atom or the like; X is N(R7a) or the like; R7a is a hydrogen atom or the like; R3 is Chemical Formula 3 or the like Ring B is a 6-membered aromatic carbocycle or the like; R9a and R10a are each independently halogen or the like; n is an integer from 1 to 5; m is an integer from 0 to 4; and p is an integer from 0 to 3, or a pharmaceutically acceptable salt thereof.

Abstract: Provided are a novel compound having an antagonistic activity for the P2X7 receptor, and a pharmaceutical composition having an antagonistic activity for the P2X7 receptor. The compound represented by Formula (I): wherein the symbols are defined in the specification, or a pharmaceutically acceptable salt thereof.

Abstract: A 90-degree hybrid circuit includes a dielectric substrate, a first conductor that includes a conductor pattern formed on the dielectric substrate and electrically conducts between a first port and a second port, a second conductor that includes a conductor pattern formed on the dielectric substrate and electrically conducts between a third port and a fourth port, and a coupled line comprising a portion of the first conductor and a portion of the second conductor that face each other on front and back sides of the dielectric substrate. A first coupled line portion as the portion of the first conductor includes a coplanar line with first ground patterns formed to sandwich the first coupled line portion from both sides. A second coupled line portion as the portion of the second conductor includes a coplanar line with second ground patterns formed to sandwich the second coupled line portion from both sides.

Abstract: A positively chargeable toner includes toner particles. Each of the toner particles includes a composite core and a shell layer covering a surface of the composite core. Each of the composite cores is a composite of a toner core containing a binder resin and a colorant layer disposed over a surface of the toner core. The colorant layers contain carbon black. The colorant layers have a thickness of at least 200 nm and no greater than 500 nm. The shell layers include a repeating unit having a non-ring-opened oxazoline group. An amount of the non-ring-opened oxazoline group contained in 1 g of the positively chargeable toner as measured by gas chromatography-mass spectrometry is at least 500 ?mol and no greater than 1,000 ?mol.

Abstract: A power feed circuit for feeding power to first through fifth antenna elements sequentially arranged in a horizontal direction includes a 90-degree hybrid circuit including two input terminals and two output terminals, an equal distribution circuit that the power-feed signal output from one of the output terminals is equally distributed and output to the second and fourth antenna elements, and a distribution circuit that power-feed signal output from the other of the output terminals is distributed and output to the first, third and fifth antenna elements. The distribution circuit distributes such that electrical power output to the first and fifth antenna elements is equal and that a sum of electrical power output to the first and fifth antenna elements is not more than that output to the third antenna element. A phase-inverted power is fed to the third antenna element and either one of the second and fourth antenna elements.

Abstract: In a method of baking both sides of ingredients between upper and lower dies with upper and lower electric heaters respectively, a temperature of one of the lower and upper dies is detected. Based on temperature information detected thereby, consumed power of the other of the lower and upper dies is controlled, thereby making a temperature of the lower die closer to that of the upper die, thereby baking both sides of the ingredients.

Abstract: An antenna device includes a plurality of antenna element groups including a plurality of antenna elements arranged in a horizontal direction. The plurality of antenna element groups are arranged in multiple stages in a vertical direction. The stage antenna element group includes a first antenna element group in which the antenna element in an even number sequence from the antenna element configuring the antenna element group is arranged at a shifted position to an upper side or a lower side in the vertical direction from the antenna element in an odd number sequence, and a second antenna element group in which the antenna element in the even number sequence from the antenna element configuring the antenna element group is arranged at a shifted position to the other side of the lower side or the upper side in the vertical direction from the antenna element in the odd number sequence.

Abstract: An antenna device includes a plurality of antenna elements, a metal member integrally including a first wall and a plurality of second walls that are arranged in parallel to each other and perpendicularly extend from one surface of the first wall, and circuit boards that are respectively housed in substrate-housing spaces as gaps between the adjacent second walls and mount feeder circuits for feeding power to the plurality of antenna elements.

Abstract: Provided is a measuring instrument which is portable while enabling the measurement of the accumulation level of fluorescent substances accumulated in the skin.

Abstract: A positively chargeable toner includes toner particles. Each of the toner particles includes a composite core and a shell layer covering a surface of the composite core. Each of the composite cores is a composite of a toner core containing a binder resin and a colorant layer disposed over a surface of the toner core. The colorant layers contain carbon black. The colorant layers have a thickness of at least 200 nm and no greater than 500 nm. The shell layers include a repeating unit having a non-ring-opened oxazoline group. An amount of the non-ring-opened oxazoline group contained in 1 g of the positively chargeable toner as measured by gas chromatography-mass spectrometry is at least 500 ?mol and no greater than 1,000 ?mol.